CD4 and lung cancer: Through single-cell sequencing of tumor tissues derived from wild-type and Trem2 knockout mice bearing subcutaneous lung cancer, it is found that TREM2 deletion hindered tumor growth, with a notable increase in and improved functionality of CD4<sup>+</sup> T and natural killer (NK) cells in the tumor microenvironment.